Americans are preparing for Covid-19 vaccines, survey finds

Above, vials of the Pfizer / BioNTech covid-19 vaccine

Above, vials of Pfizer / BioNTech covid-19 vaccine
Photo: Patrick T. Fallon (fake images)

Plus Americans are ready to get a COVID-19 vaccine, suggests a new survey. According to a survey by the Kaiser Family Foundation, Americans are more likely to have been vaccinated or want to be vaccinated in February than a month ago, while the percentage of people who want to wait and see has also decreased.

KFF’s COVID-19 Vaccine Monitor has been tracking people’s enthusiasm for a COVID-19 vaccine since last December, through a nationally representative survey conducted by phone. The latter poll involved more than 1,800 adults interviewed between February 15 and 23, 2021.

For the first time in their survey, a slight majority of Americans (55%) have received at least one dose of the vaccine (18%) or are looking to receive it as soon as possible (37%). That’s up from the 47% and 34% who said the same in January and December, respectively. The percentage of people who wait for others to take it before making a decision has also dropped, from 31% in January to 22% in February.

The positive numbers are even more encouraging in light of the constantand improving vaccine launch In the US As of Friday, 47.2 million Americans have received at least one dose of the Moderna or Pfizer / BioNTech vaccines, while 22 million have been fully vaccinated with two doses. And access to vaccines will soon be even easier.

This weekend, the Food and Drug Administration provided grant authorization for the emergency use of the single-dose vaccine developed by Johnson & Johnson, making it the third available in the United States. public. Once authorized, the company has committed to shipping nearly 4 million doses immediately for distribution, along with a total of 20 million doses by the end of March. Moderna and Pfizer / BioNTech have promised that they will produce 220 million combined doses by the end of next month..

J & J’s more convenient vaccine might make at least some people more comfortable with vaccination. Of the people who still wanted to wait and see, 26% said they would be more willing to get a vaccine if it only required one dose. Other concerns cited by this group included potentially serious side effects or a concern that the vaccine would give them COVID-19. True-global data continues to support the safety and efficacy of both mRNA vaccines, however, and neither vaccine available capable of giving people covid-19 as they do not contain the actual coronavirus.

Enthusiasm for the vaccine increased in all demographic groups, but African Americans and Hispanic Americans were more likely to express caution about vaccination. They were also more likely to worry about potential problems, such as not being able to afford the vaccine or to obtain it from a trusted source. and worry about not having the vaccine sufficiently proven in your specific demographic. Public health experts have continued to emphasize the importance of building trust among these communities and correcting misinformation whenever possible. For example, all covid-19 vaccines will be available for free.

There it remains a small minority of Americans who will find it more difficult to give in to their doubts about vaccines. About 15% in the survey said they would “definitely not” get vaccinated, while another 7% said they would only get a vaccine if needed for work, school or other activities, numbers that haven’t changed much since December.

Ththese vaccines are prepared to turn the tide of the pandemic and reduce deaths, hospitalizations, and new cases, Y there seems to be many people that is willing to take advantage of them as they become available.


Source link